GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stryker Corporation (SYK) [hlAlert]

Rating:
Buy SYK
up 73.46 %

Stryker Corporation (SYK) rated Buy with price target $65 by Stifel Nicolaus

Posted on: Tuesday,  Nov 20, 2012  9:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Stryker Corporation (NYSE: SYK) on 11/20/2012. Previously Stifel Nicolaus rated Buy Stryker Corporation (NYSE: SYK) on 01/11/2011.,
when the stock price was $58.27. Since then, Stryker Corporation has gained 73.47% as of 01/08/2016's recent price of $101.08.
If you would have followed the previous Stifel Nicolaus's recommendation on SYK, you would have gained 73.46% of your investment in 1823 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/20/2012 9:25 AM Buy
None
52.90 65.00
as of 12/31/2012
1 Week down  -1.87 %
1 Month up  1.21 %
3 Months down  -1.50 %
1 YTD up  10.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/25/2012 8:25 AM Buy
None
53.72 61.00
9/27/2011 8:25 AM Buy
None
48.60 61.00
3/2/2011 8:25 AM Buy
None
62.62 68.00
1/11/2011 8:25 AM Buy
None
58.27 63.00
9/2/2010 8:25 AM Hold
None
44.87 50.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy